DK1328266T3 - Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion - Google Patents

Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion

Info

Publication number: DK1328266T3
Authority: DK; Denmark
Prior art keywords: fenofibrate; coenzyme; combination; endothelial dysfunction; treat endothelial
Prior art date: 2000-10-26

Application number

DK01988586T

Other languages

English (en)

Inventor

Gerald Watts

David Playford

Original Assignee

Fournier Lab Ireland Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-26

Filing date

2001-10-23

Publication date

2006-06-06

2000-10-26 Priority claimed from AUPR1038A external-priority patent/AUPR103800A0/en

2001-02-28 Priority claimed from AUPR3424A external-priority patent/AUPR342401A0/en

2001-10-23 Application filed by Fournier Lab Ireland Ltd filed Critical Fournier Lab Ireland Ltd

2006-06-06 Application granted granted Critical

2006-06-06 Publication of DK1328266T3 publication Critical patent/DK1328266T3/da

Links

ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 title 1
206010048554 Endothelial dysfunction Diseases 0.000 title 1
235000017471 coenzyme Q10 Nutrition 0.000 title 1
ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title 1
229940110767 coenzyme Q10 Drugs 0.000 title 1
230000008694 endothelial dysfunction Effects 0.000 title 1
YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 title 1
229960002297 fenofibrate Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK01988586T 2000-10-26 2001-10-23 Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion DK1328266T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPR1038A AUPR103800A0 (en)	2000-10-26	2000-10-26	Compositions for the treatment of endothelial dysfunction
AUPR3424A AUPR342401A0 (en)	2001-02-28	2001-02-28	Compositions for the treatment of endothelial dysfunction

Publications (1)

Publication Number	Publication Date
DK1328266T3 true DK1328266T3 (da)	2006-06-06

Family

ID=25646491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01988586T DK1328266T3 (da)	2000-10-26	2001-10-23	Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion

Country Status (29)

Country	Link
US (1)	US7410983B2 (da)
EP (1)	EP1328266B1 (da)
JP (1)	JP4236464B2 (da)
KR (1)	KR100862129B1 (da)
CN (1)	CN1220488C (da)
AR (1)	AR035071A1 (da)
AT (1)	ATE316787T1 (da)
AU (1)	AU2176502A (da)
BG (1)	BG65979B1 (da)
BR (1)	BR0114701A (da)
CA (1)	CA2426625C (da)
CY (1)	CY1105007T1 (da)
CZ (1)	CZ301282B6 (da)
DE (1)	DE60117046T2 (da)
DK (1)	DK1328266T3 (da)
DZ (1)	DZ3442A1 (da)
EE (1)	EE05281B1 (da)
ES (1)	ES2257457T3 (da)
HU (1)	HUP0303566A3 (da)
IL (2)	IL155524A0 (da)
MA (1)	MA25847A1 (da)
MX (1)	MXPA03003733A (da)
NO (1)	NO332260B1 (da)
PL (1)	PL212952B1 (da)
PT (1)	PT1328266E (da)
RU (1)	RU2003111175A (da)
SK (1)	SK287992B6 (da)
TN (1)	TNSN01151A1 (da)
WO (1)	WO2002034259A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2004536845A (ja)	2001-07-11	2004-12-09	ベーリンガーインゲルハイムファーマシューティカルズインコーポレイテッド	サイトカイン媒介疾患の治療方法
WO2003075911A1 (en) *	2002-03-11	2003-09-18	Peter Zahradka	Use of ppar alpha agonists for the treatment of vascular and renal diseases
US20070225614A1 (en) *	2004-05-26	2007-09-27	Endothelix, Inc.	Method and apparatus for determining vascular health conditions
FR2845602B1 (fr) *	2002-10-11	2005-07-08	Servier Lab	Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
GB0309154D0 (en)	2003-01-14	2003-05-28	Aventis Pharma Inc	Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia
JP2005104951A (ja) *	2003-01-17	2005-04-21	Kirin Brewery Co Ltd	血圧降下用組成物および血管柔軟性改善用組成物並びにこれらの機能が付与された食品
FR2868313B1 (fr) *	2004-03-31	2008-08-15	Servier Lab	Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
EP1621200A1 (en) *	2004-07-26	2006-02-01	Fournier Laboratories Ireland Limited	Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
EP2471530B1 (en)	2005-06-01	2017-01-11	Edison Pharmaceuticals, Inc.	Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
CA2622523C (en)	2005-09-15	2014-02-18	Edison Pharmaceuticals, Inc.	Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EP1785133A1 (en) *	2005-11-10	2007-05-16	Laboratoires Fournier S.A.	Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
US9278085B2 (en)	2006-02-22	2016-03-08	Edison Pharmaceuticals, Inc.	Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
WO2007106912A2 (en) *	2006-03-16	2007-09-20	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Peroxisome-proliferator activated receptor-alpha agonists for organ preservation
US20070225606A1 (en) *	2006-03-22	2007-09-27	Endothelix, Inc.	Method and apparatus for comprehensive assessment of vascular health
US20080027330A1 (en) *	2006-05-15	2008-01-31	Endothelix, Inc.	Risk assessment method for acute cardiovascular events
US20080081963A1 (en) *	2006-09-29	2008-04-03	Endothelix, Inc.	Methods and Apparatus for Profiling Cardiovascular Vulnerability to Mental Stress
KR100989093B1 (ko)	2008-01-18	2010-10-25	한화제약주식회사	생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
EP2344142B1 (en)	2008-09-10	2024-06-26	PTC Therapeutics, Inc.	Treatment of pervasive developmental disorders with redox-active therapeutics
US20110305755A1 (en) *	2009-01-29	2011-12-15	Levine Joshua D	Method of adding botanical agents/dietary supplements to pharmaceutical agents in a pharmacotherapeutic regimen
US8973851B2 (en)	2009-07-01	2015-03-10	The Procter & Gamble Company	Apparatus and methods for producing charged fluid droplets
WO2011117429A1 (es) *	2010-03-26	2011-09-29	Vivacell Biotechnology España, S.L	Derivados quinona de cannabinoides
RU2554500C2 (ru) *	2013-09-20	2015-06-27	Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Способ лечения ишемического инсульта
WO2017106803A1 (en)	2015-12-17	2017-06-22	Bioelectron Technology Corporation	Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US10881686B2 (en)	2017-10-27	2021-01-05	Zeta Biolongevity, Inc	Compositions and methods for treating and preventing proteinuria and endothelial erosion
CN110907407B (zh) *	2019-12-03	2022-02-25	东北石油大学	一种基于spr的高灵敏度光子准晶体光纤折射率传感器

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5229385A (en) *	1986-01-30	1993-07-20	Takeda Chemical Industries, Ltd.	Quinone derivatives, their production and use
FR2627696B1 (fr)	1988-02-26	1991-09-13	Fournier Innovation Synergie	Nouvelle forme galenique du fenofibrate
FI102273B1 (fi)	1989-09-11	1998-11-13	Eisai Co Ltd	Kinonijohdannaiset, niiden valmistaminen ja niiden farmakologinen käyttö
FR2730231B1 (fr) *	1995-02-02	1997-04-04	Fournier Sca Lab	Association de fenofibrate et de vitamine e, utilisation en therapeutique
US6063407A (en) *	1995-02-16	2000-05-16	The General Hospital Corporation	Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
AU1856997A (en) *	1996-02-02	1997-08-22	Merck & Co., Inc.	Method for raising hdl cholesterol levels
GB9606805D0 (en) *	1996-03-30	1996-06-05	Glaxo Wellcome Inc	Medicaments
EP1034791A1 (en)	1997-11-28	2000-09-13	Nikolai Vasilievich Karsanov	Anti-hypoxic and anti-ischemic drug
US6423742B1 (en) *	1999-09-02	2002-07-23	Drake Larson	Compositions for reducing vascular plaque formation and methods of using same

2001
- 2001-10-23 MX MXPA03003733A patent/MXPA03003733A/es active IP Right Grant
- 2001-10-23 PL PL361635A patent/PL212952B1/pl not_active IP Right Cessation
- 2001-10-23 DE DE60117046T patent/DE60117046T2/de not_active Expired - Lifetime
- 2001-10-23 EE EEP200300165A patent/EE05281B1/xx not_active IP Right Cessation
- 2001-10-23 JP JP2002537311A patent/JP4236464B2/ja not_active Expired - Fee Related
- 2001-10-23 RU RU2003111175/15A patent/RU2003111175A/ru not_active Application Discontinuation
- 2001-10-23 CZ CZ20031148A patent/CZ301282B6/cs not_active IP Right Cessation
- 2001-10-23 US US10/399,639 patent/US7410983B2/en not_active Expired - Fee Related
- 2001-10-23 SK SK508-2003A patent/SK287992B6/sk unknown
- 2001-10-23 CN CNB01817972XA patent/CN1220488C/zh not_active Expired - Fee Related
- 2001-10-23 BR BR0114701-3A patent/BR0114701A/pt not_active Application Discontinuation
- 2001-10-23 PT PT01988586T patent/PT1328266E/pt unknown
- 2001-10-23 ES ES01988586T patent/ES2257457T3/es not_active Expired - Lifetime
- 2001-10-23 DZ DZ013442A patent/DZ3442A1/fr active
- 2001-10-23 EP EP01988586A patent/EP1328266B1/en not_active Expired - Lifetime
- 2001-10-23 HU HU0303566A patent/HUP0303566A3/hu unknown
- 2001-10-23 CA CA2426625A patent/CA2426625C/en not_active Expired - Fee Related
- 2001-10-23 KR KR1020037004793A patent/KR100862129B1/ko not_active Expired - Fee Related
- 2001-10-23 IL IL15552401A patent/IL155524A0/xx active IP Right Grant
- 2001-10-23 AT AT01988586T patent/ATE316787T1/de active
- 2001-10-23 AU AU2176502A patent/AU2176502A/xx active Pending
- 2001-10-23 WO PCT/EP2001/012425 patent/WO2002034259A1/en not_active Ceased
- 2001-10-23 DK DK01988586T patent/DK1328266T3/da active
- 2001-10-25 TN TNTNSN01151A patent/TNSN01151A1/en unknown
- 2001-10-26 AR ARP010105032A patent/AR035071A1/es unknown
2003
- 2003-04-21 IL IL155524A patent/IL155524A/en not_active IP Right Cessation
- 2003-04-24 NO NO20031851A patent/NO332260B1/no not_active IP Right Cessation
- 2003-04-25 BG BG107765A patent/BG65979B1/bg unknown
- 2003-04-25 MA MA27124A patent/MA25847A1/fr unknown
2006
- 2006-03-21 CY CY20061100400T patent/CY1105007T1/el unknown

Also Published As

Publication number	Publication date
AR035071A1 (es)	2004-04-14
US20040022778A1 (en)	2004-02-05
ES2257457T3 (es)	2006-08-01
CN1220488C (zh)	2005-09-28
NO332260B1 (no)	2012-08-13
EE200300165A (et)	2003-06-16
IL155524A (en)	2008-08-07
PL212952B1 (pl)	2012-12-31
IL155524A0 (en)	2003-11-23
DE60117046D1 (de)	2006-04-13
EP1328266A1 (en)	2003-07-23
SK5082003A3 (en)	2003-11-04
RU2003111175A (ru)	2004-09-10
DZ3442A1 (fr)	2002-05-02
NO20031851D0 (no)	2003-04-24
TNSN01151A1 (en)	2005-11-10
BR0114701A (pt)	2003-11-18
WO2002034259A1 (en)	2002-05-02
CN1471390A (zh)	2004-01-28
HUP0303566A3 (en)	2005-05-30
CY1105007T1 (el)	2009-11-04
BG107765A (bg)	2004-02-27
PT1328266E (pt)	2006-05-31
HK1057340A1 (en)	2004-04-02
EP1328266B1 (en)	2006-02-01
SK287992B6 (sk)	2012-09-03
EE05281B1 (et)	2010-04-15
AU2176502A (en)	2002-05-06
DE60117046T2 (de)	2006-09-28
KR100862129B1 (ko)	2008-10-09
CA2426625C (en)	2010-06-01
KR20030055276A (ko)	2003-07-02
ATE316787T1 (de)	2006-02-15
BG65979B1 (bg)	2010-08-31
NO20031851L (no)	2003-06-24
JP2004512302A (ja)	2004-04-22
PL361635A1 (en)	2004-10-04
CZ301282B6 (cs)	2009-12-30
MXPA03003733A (es)	2004-10-15
MA25847A1 (fr)	2003-07-01
CA2426625A1 (en)	2002-05-02
US7410983B2 (en)	2008-08-12
HUP0303566A2 (hu)	2004-03-01
JP4236464B2 (ja)	2009-03-11

Publication	Publication Date	Title
DK1328266T3 (da)	2006-06-06	Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion
ATE424413T1 (de)	2009-03-15	Analoge des glucagon-ähnlichen peptids-1
DE60111534D1 (de)	2005-07-21	Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
DE60105443D1 (de)	2004-10-14	Geschäumte bohrlochzementschlämme
ID30590A (id)	2002-01-03	Celana sekali pakai jenis-celana pendek
DE60128652D1 (de)	2007-07-12	Prostatischer stent zur erleichterung der drainage
DK1212317T3 (da)	2005-01-24	Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser
DK1334182T3 (da)	2011-01-17	Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
DK1392292T3 (da)	2006-05-29	Pyranoindazoler og deres anvendelse til behandling af glaukom
DE60106968D1 (de)	2004-12-09	Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
DE50112129D1 (de)	2007-04-12	Wasserklosett
DK1345598T3 (da)	2008-02-04	Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser
NO20023467L (no)	2002-09-03	Alkylbenzensulfonater på fast form og rensesammensetninger med ökt vannhardhetstoleranse
DK1248608T3 (da)	2004-04-05	Diacerein til anvendelse i behandling af psoriasis
DE60107627D1 (de)	2005-01-13	Sauerstoff und Wasserdampf absorbierende Zusammensetzung
DE50112505D1 (de)	2007-06-28	Schäranlage und Schärverfahren
NO20030978L (no)	2003-04-16	Behandling av urindysfunksjon
DK1259515T3 (da)	2005-01-31	Thienopyridinderivater og deres anvendelse som antiinflammatoriske midler
DK1381620T3 (da)	2006-06-26	Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationer
PT1273556E (pt)	2006-08-31	Estacao de tratamento simbiotico de aguas residuais.
DK1228027T3 (da)	2004-07-19	3-heteroatomsubstituerede og to carbonhomologe af 15-HETE og fremgangsmåder til anvendelse
DK1680405T3 (da)	2009-05-04	Bengamidderivater og deres anvendelse til behandling af kræftsygdomme
ATA2102000A (de)	2001-10-15	Wasserklosett
ATA8832000A (de)	2001-11-15	Wasserführung
SI1328266T1 (sl)	2006-06-30	Kombinacija fenofibrata in koencima Q10 za zdravljenje endotelialne disfunkcije